OTC Pharmaceuticals - Benelux

  • Benelux
  • Revenue in the OTC Pharmaceuticals market amounts to US$2,297.00m in 2024. The market is expected to grow annually by 3.25% (CAGR 2024-2029).
  • The market's largest segment is the segment Cold & Cough Remedies with a market volume of US$482.60m in 2024.
  • In global comparison, most revenue is generated in the United States (US$41,240m in 2024).
  • In relation to total population figures, per person revenues of US$76.45 are generated in 2024.
  • In the OTC Pharmaceuticals market, 22.8% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in Benelux is experiencing steady growth due to a combination of factors. Customer preferences for self-medication and convenience are driving the demand for over-the-counter products.

The market is also benefiting from favorable macroeconomic conditions and local special circumstances. Customer preferences in Benelux are shifting towards self-medication and a preference for convenience. Consumers are increasingly seeking accessible and affordable healthcare options, and over-the-counter pharmaceuticals provide a convenient solution.

The ease of purchasing these products without a prescription allows consumers to quickly address common health issues without the need for a doctor's visit. Additionally, the availability of a wide range of OTC products caters to the diverse needs and preferences of consumers in the region. The OTC Pharmaceuticals market in Benelux is witnessing several trends.

Firstly, there is a growing demand for natural and herbal remedies. Consumers are becoming more conscious of their health and are seeking alternative solutions that are perceived as safer and more sustainable. This trend is driving the growth of herbal and natural OTC products in the market.

Secondly, there is an increasing focus on preventive healthcare. Consumers are becoming proactive in maintaining their health and are turning to OTC products for preventive measures. This includes vitamins, supplements, and other preventive medications that help boost immunity and overall well-being.

Another trend in the market is the rise of e-commerce. Online platforms provide consumers with a convenient and accessible way to purchase OTC products. The ease of comparing prices, reading reviews, and accessing a wide range of products online has contributed to the growth of e-commerce in the OTC Pharmaceuticals market in Benelux.

Local special circumstances in Benelux also contribute to the development of the OTC Pharmaceuticals market. The region has a well-developed healthcare system with a high level of accessibility to healthcare services. This, combined with a high level of health literacy among the population, creates a conducive environment for the growth of the OTC market.

Furthermore, the aging population in Benelux is driving the demand for OTC pharmaceuticals. As the population ages, there is an increased need for self-care and management of chronic conditions. OTC products provide a convenient and cost-effective solution for managing these conditions.

Underlying macroeconomic factors, such as stable economic growth and increasing disposable incomes, are also fueling the growth of the OTC Pharmaceuticals market in Benelux. As consumers have more disposable income, they are willing to spend on healthcare products, including OTC pharmaceuticals. In conclusion, the OTC Pharmaceuticals market in Benelux is experiencing steady growth due to customer preferences for self-medication and convenience, as well as favorable macroeconomic conditions and local special circumstances.

The market is witnessing trends such as the demand for natural and preventive healthcare products, the rise of e-commerce, and the aging population. These factors, combined with stable economic growth and increasing disposable incomes, contribute to the development of the OTC Pharmaceuticals market in Benelux.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)